InfinityQS Fulfills $1-Million Pledge to Support St. Jude Children's Research Hospital - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
InfinityQS Fulfills $1-Million Pledge to Support St. Jude Children's Research Hospital Global authority on Manufacturing Intelligence and enterprise quality helps fund research, cures for pediatric cancer and other deadly diseases


InfinityQS Fulfills $1-Million Pledge to Support St. Jude Children's Research Hospital

Global authority on Manufacturing Intelligence and enterprise quality helps fund research, cures for pediatric cancer and other deadly diseases

PR Newswire

FAIRFAX, Va., June 3, 2014 /PRNewswire/ -- InfinityQS International, Inc., the global authority on real-time quality and Manufacturing Intelligence, is proud to announce the fulfillment of its $1-million pledge to St. Jude Children's Research Hospital®, which is leading the way the world understands, treats and defeats childhood cancer and other deadly diseases. A longtime supporter of St. Jude, InfinityQS committed in 2009 to donating $1 million within 10 years and was able to accelerate its philanthropic schedule to fulfill its commitment within five years.

InfinityQS is the global authority on Manufacturing Intelligence and enterprise quality, servicing more than 40,000 active
               licenses with over 2,500 of the world's top manufacturers. For more information, visit www.infinityqs.com.

To commemorate the company's support, St. Jude has named the international virology lab of Richard J. Webby, Ph.D., in honor of InfinityQS. Dr. Webby is a member of the St. Jude Department of Infectious Diseases and director of the World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds.  

In 2013, InfinityQS received the Cardinal Stritch Donor of the Year Award, which recognizes a donor whose commitment reflects the vision and leadership of St. Jude founder Danny Thomas' spiritual mentor, Samuel Cardinal Stritch, the Catholic archbishop of Chicago. InfinityQS has also sponsored and participated in three of the hospital's annual St. Jude Memphis Marathon Weekend fundraisers.

"We are deeply appreciative to InfinityQS for the support they have provided St. Jude to help find cures and save children with cancer and other deadly diseases," said Richard Shadyac, Jr., CEO of ALSAC/St. Jude Children's Research Hospital. "We are honored to recognize their generous $1-million gift with the naming of our international virology lab which will help to further our mission of helping some of the world's sickest children." 

Michael Lyle, president and CEO, InfinityQS, said, "At InfinityQS, we approach success with a commitment to do well while doing good. The fulfillment of our $1-million donation to St. Jude Children's Research Hospital represents that mission, and we are incredibly proud that our philanthropic efforts have contributed to an organization that does such critical work to prevent and cure deadly diseases in children."

Charitable donations from companies like InfinityQS have helped St. Jude make tremendous strides in discovering new cures for children afflicted by disease. Because of funding from contributors, patient families never receive a bill from the hospital for treatment, travel, housing or food, and St. Jude has the freedom to focus on what matters most – saving children's lives, regardless of their financial situation.

About InfinityQS International, Inc.
InfinityQS International, Inc.® is the global authority on real-time quality and Manufacturing Intelligence. The company's Manufacturing Intelligence platform, ProFicient, delivers real-time visibility from the shop floor, across the enterprise and into the supply chain, allowing top manufacturers to take control of quality. Powered by a centralized statistical process control (SPC) analytical engine, ProFicient manufacturing quality software leverages Manufacturing Intelligence to help global manufacturers improve product quality, decrease costs, maintain compliance and make smarter, data-driven business decisions. Headquartered in Fairfax, Va., and founded in 1989, InfinityQS now services more than 40,000 active licenses with over 2,500 of the world's top manufacturers including Kraft Foods, Ball Corporation, Boston Scientific, Graham Packaging and Medtronic. For more information, visit www.infinityqs.com.

Media Contact:

Company Contact:

Liz Palm

Emily Bradford

DPR Group, Inc.

InfinityQS

(240) 686-1000

(703) 961-0200 ext. 2064

epalm@dprgroup.com

ebradford@infinityqs.com

Logo - http://photos.prnewswire.com/prnh/20140505/84665 

SOURCE InfinityQS International, Inc.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
7%
Create entirely its own pathway program?
7%
View Results
Untitled Document

Click here